170 related articles for article (PubMed ID: 2667681)
21. The actions of the peptides, neuropeptide Y and peptide YY, on the vascular and capsular smooth muscle of the isolated, blood-perfused spleen of the dog.
Corder R; Lowry PJ; Withrington PG
Br J Pharmacol; 1987 Apr; 90(4):785-90. PubMed ID: 3580708
[TBL] [Abstract][Full Text] [Related]
22. Inhibition by amlodipine of activity evoked in isolated human coronary arteries by endothelin, prostaglandin F2 alpha and depolarization.
Godfraind T; Mennig D; Bravo G; Chalant C; Jaumin P
Am J Cardiol; 1989 Nov; 64(17):58I-64I. PubMed ID: 2530886
[TBL] [Abstract][Full Text] [Related]
23. Influence of endothelin on human coronary arteries and localization of its binding sites.
Chester AH; Dashwood MR; Clarke JG; Larkin SW; Davies GJ; Tadjkarimi S; Maseri A; Yacoub MH
Am J Cardiol; 1989 Jun; 63(18):1395-8. PubMed ID: 2658527
[TBL] [Abstract][Full Text] [Related]
24. Diminished contractile responses to neuropeptide Y of arteries from diabetic rabbits.
Andersson D; Brunkwall J; Bergqvist D; Edvinsson L
J Auton Nerv Syst; 1992 Mar; 37(3):215-22. PubMed ID: 1587998
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effects of TAK-044 on endothelin induced vasoconstriction in various canine arteries and porcine coronary arteries: a comparison with selective ETA and ETB receptor antagonists.
Awane-Igata Y; Ikeda S; Watanabe T
Br J Pharmacol; 1997 Feb; 120(3):516-22. PubMed ID: 9031758
[TBL] [Abstract][Full Text] [Related]
26. Effect of endothelin as a coronary vasoconstrictor in the Langendorff-perfused rat heart.
Fukuda K; Hori S; Kusuhara M; Satoh T; Kyotani S; Handa S; Nakamura Y; Oono H; Yamaguchi K
Eur J Pharmacol; 1989 Jun; 165(2-3):301-4. PubMed ID: 2673800
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological characteristics of the canine cerebrovascular constriction produced by neuropeptide Y.
Uneyama H; Tanaka Y; Iwata S; Ishiguro T; Nakayama K
Biol Pharm Bull; 1995 Apr; 18(4):501-6. PubMed ID: 7655416
[TBL] [Abstract][Full Text] [Related]
28. Potentiation by neuropeptide Y of vasoconstriction in rat resistance arteries.
Andriantsitohaina R; Stoclet JC
Br J Pharmacol; 1988 Oct; 95(2):419-28. PubMed ID: 2465806
[TBL] [Abstract][Full Text] [Related]
29. Endothelium removal does not affect potentiation by neuropeptide Y in rabbit ear artery.
Budai D; Vu HQ; Duckles SP
Eur J Pharmacol; 1989 Sep; 168(1):97-100. PubMed ID: 2583236
[TBL] [Abstract][Full Text] [Related]
30. Endothelin is a potent long-lasting vasoconstrictor in men.
Clarke JG; Benjamin N; Larkin SW; Webb DJ; Davies GJ; Maseri A
Am J Physiol; 1989 Dec; 257(6 Pt 2):H2033-5. PubMed ID: 2690644
[TBL] [Abstract][Full Text] [Related]
31. Conversion of big endothelin-1 to 21-residue endothelin-1 is essential for expression of full vasoconstrictor activity: structure-activity relationships of big endothelin-1.
Kimura S; Kasuya Y; Sawamura T; Shinimi O; Sugita Y; Yanagisawa M; Goto K; Masaki T
J Cardiovasc Pharmacol; 1989; 13 Suppl 5():S5-7; discussion S18. PubMed ID: 2473327
[TBL] [Abstract][Full Text] [Related]
32. The adrenomedullary venous vasculature as a target for endothelins: comparison of the porcine and bovine central adrenomedullary veins.
Bjerkås H; Lønning K; Helle KB
Comp Biochem Physiol A Mol Integr Physiol; 1998 Jul; 120(3):439-46. PubMed ID: 9787829
[TBL] [Abstract][Full Text] [Related]
33. Neuropeptide Y is a vasoconstrictor of human coronary arteries.
Tseng CJ; Robertson D; Light RT; Atkinson JR; Robertson RM
Am J Med Sci; 1988 Jul; 296(1):11-6. PubMed ID: 3407677
[TBL] [Abstract][Full Text] [Related]
34. Neuropeptide Y inhibits relaxation of guinea pig cerebral, coronary, and uterine arteries: blockade by D-myo-inositol-1,2,6-triphosphate.
Edvinsson L; Adamsson M
J Cardiovasc Pharmacol; 1992 Sep; 20(3):466-72. PubMed ID: 1279294
[TBL] [Abstract][Full Text] [Related]
35. Enhanced neuropeptide Y immunoreactivity and vasoconstriction in mesenteric small arteries from spontaneously hypertensive rats.
Gradin KA; Li JY; Andersson O; Simonsen U
J Vasc Res; 2003; 40(3):252-65. PubMed ID: 12902638
[TBL] [Abstract][Full Text] [Related]
36. Direct positive inotropic and vasoconstrictor effects of endothelin.
Siegfried MR; Aoki N; Mulloy D; Lefer AM
Heart Vessels; 1990; 5(3):146-51. PubMed ID: 2193909
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of the biphasic responses to endothelin-3 in dog coronary arteries.
Okamura T; Matsumoto T; Ikemoto F; Toda N
Br J Pharmacol; 1992 Dec; 107(4):1037-41. PubMed ID: 1467826
[TBL] [Abstract][Full Text] [Related]
38. Effects of neuropeptide Y and calcitonin gene-related peptide on sheep coronary artery rings under oxygenated, hypoxic and simulated myocardial ischaemic conditions.
Kwan YW; Wadsworth RM; Kane KA
Br J Pharmacol; 1990 Apr; 99(4):774-8. PubMed ID: 2361172
[TBL] [Abstract][Full Text] [Related]
39. Effects of thiopental, pentobarbital, and ketamine on endothelin-induced constriction of porcine cerebral arteries.
Taga K; Fukuda S; Nishimura N; Tsukui A; Morioka M; Shimoji K
Anesthesiology; 1990 May; 72(5):939-41. PubMed ID: 2187378
[TBL] [Abstract][Full Text] [Related]
40. Neuropeptide Y potentiates contraction and inhibits relaxation of rabbit coronary arteries.
Han C; Abel PW
J Cardiovasc Pharmacol; 1987 Jun; 9(6):675-81. PubMed ID: 2442533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
